Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.

Ridgway, Harry; Moore, Graham J; Mavromoustakos, Thomas; Tsiodras, Sotirios; Ligielli, Irene; Kelaidonis, Konstantinos; Chasapis, Christos T; Gadanec, Laura Kate; Zulli, Anthony; Apostolopoulos, Vasso; Petty, Russell; Karakasiliotis, Ioannis; Gorgoulis, Vassilis G; Matsoukas, John M

Ridgway, Harry; Moore, Graham J; Mavromoustakos, Thomas; Tsiodras, Sotirios; Ligielli, Irene; Kelaidonis, Konstantinos; Chasapis, Christos T; Gadanec, Laura Kate; Zulli, Anthony; Apostolopoulos, Vasso; Petty, Russell; Karakasiliotis, Ioannis; Gorgoulis, Vassilis G; Matsoukas, John M.

Afiliación

Ridgway H; Institute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, Australia.
Moore GJ; AquaMem Consultants, Rodeo, NM, USA.
Mavromoustakos T; Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada.
Tsiodras S; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada.
Ligielli I; Department of Chemistry, National Kapodistrian University of Athens, Greece.
Kelaidonis K; Faculty of Medicine, 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Chasapis CT; Department of Chemistry, National Kapodistrian University of Athens, Greece.
Gadanec LK; NewDrug PC, Patras Science Park, Patras, 26504, Greece.
Zulli A; NMR Facility, Instrumental Analysis Laboratory, School of Natural Sciences, University of Patras, Patras, Greece.
Apostolopoulos V; Institute of Chemical Engineering Sciences, Foundation for Research and Technology, Hellas (FORTH/ICE-HT), Patras, Greece.
Petty R; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia.
Karakasiliotis I; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia.
Gorgoulis VG; Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia.
Matsoukas JM; Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC Australia.

Comput Struct Biotechnol J ; 20: 2091-2111, 2022.

Article en En | MEDLINE | ID: mdl-35432786

Palabras clave

Angiotensin receptors; Animal AT1 receptor studies; Azil, Azilsartan; BisA, 4-Butyl-N,N0-bis{[[20-(2H-tetrazol-5-yl)]biphenyl-4-yl] methyl}imidazolium bromide; BisB, 4-Butyl-2-hydroxymethyl-N,N0-bis{[20-(2H-tetrazol-5-yl)- biphenyl-4-yl]methyimidazolium bromide; BisC, 2-Butyl-4-chloro-5-hydroxymethyl-N,N0-bis{[20-(2H-tetrazol- 5-yl)biphenyl-4-yl]methyl}imidazolium bromide; BisD, 2-Butyl-N,N0-bis{[20-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl} imidazolium bromide; Bisartan NMR studies; Bisartans tetrazole; Cande, Candesartan; DIZE, deminazene aceturate; Docking RBD/ACE2 studies; EXP3174, losartan carboxylic acid; Epro, Eprosartan; Irbe, Irbesartan; Lo, Losartan; Olme, Olmesartan; SARS-CoV-2 spike/ACE2 complex blockers; Sartans; Telmi, Telmisartan; Val, Valsartan

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Comput Struct Biotechnol J Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google